Madrigal Pharmaceuticals MDGL
NASDAQ MDGL
$434.24 -19.10 (-4.21%)
At close: Oct 23, 2026 · 4:00 PM EDT

Madrigal Pharmaceuticals (MDGL) Sale and Maturity of Investments (2011 - 2026)

Updated

Analysis

Madrigal Pharmaceuticals (MDGL) Sale and Maturity of Investments (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Madrigal Pharmaceuticals 12.66 Bn 8.91 Bn - 187.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 187.30 Mn
Mar 31, 2026 353.87 Mn
Dec 31, 2025 240.15 Mn
Sep 30, 2025 275.07 Mn
Jun 30, 2025 273.39 Mn
Mar 31, 2025 294.69 Mn
Dec 31, 2024 302.43 Mn
Sep 30, 2024 214.42 Mn
Jun 30, 2024 163.82 Mn
Mar 31, 2024 182.61 Mn
Dec 31, 2023 113.80 Mn
Sep 30, 2023 238.78 Mn
Jun 30, 2023 176.42 Mn
Mar 31, 2023 23.99 Mn
Dec 31, 2022 79.20 Mn
Sep 30, 2022 79.37 Mn
Jun 30, 2022 98.27 Mn
Mar 31, 2022 93.55 Mn
Dec 31, 2021 70.51 Mn
Sep 30, 2021 155.44 Mn
API Access

Madrigal Pharmaceuticals Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=MDGL&period=max&api_key=YOUR_API_KEY